European Commission approves Janssen-Cilag International Rybrevant, Lazcluze combo for first-line treatment of lung cancer Ruchika Sharma31 Dec 2024 11:30 AM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the European Commission (EC) has approved a Type II...
AstraZeneca Tagrisso approved in EU for patients with unresectable EGFR-mutated lung cancer Ruchika Sharma27 Dec 2024 11:30 AM ISTCambridge: AstraZeneca's Tagrisso (osimertinib) has been approved in the European Union (EU) for the treatment of adult patients with...
AstraZeneca, Daiichi Sankyo voluntarily withdraws datopotamab deruxtecan application in EU for lung cancer Ruchika Sharma25 Dec 2024 11:30 AM ISTCambridge: AstraZeneca and Daiichi Sankyo have voluntarily withdrawn the marketing authorisation application (MAA) in the EU for datopotamab...
Aurobindo Pharma arm CuraTeQ Biologics gets UK MHRA nod for cancer treatment Bevqolva Ruchika Sharma22 Dec 2024 1:30 PM ISTHyderabad: CuraTeQ Biologics s.r.o., a step-down subsidiary of Aurobindo Pharma Limited, has announced that it has obtained marketing...
Metformin may improve immunotherapy efficacy in obese lung cancer patients: Study Jacinthlyn Sylvia20 Dec 2024 9:30 AM ISTA new study published in the Journal of the National Cancer Institute found that metformin which is frequently used to regulate blood glucose levels...
Gilead Sciences earns USFDA Breakthrough Therapy Designation for lung cancer treatment Trodelvy Ruchika Sharma19 Dec 2024 1:30 PM ISTFoster City: Gilead Sciences, Inc. has announced that Trodelvy (sacituzumab govitecan-hziy) has received Breakthrough Therapy...
AstraZeneca-Daiichi Sankyo Datopotamab deruxtecan gets USFDA Breakthrough Therapy Designation for previously treated advanced EGFR-mutated non-small cell lung cancer Ruchika Sharma10 Dec 2024 12:30 PM ISTCambridge: AstraZeneca has announced that Datopotamab deruxtecan (Dato-DXd) has been granted Breakthrough Therapy Designation (BTD) in the...
AstraZeneca Imfinzi gets USFDA nod for limited-stage small cell lung cancer Ruchika Sharma6 Dec 2024 11:00 AM ISTAstraZeneca's Imfinzi (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer...
Metformin Appears to Fight Lung Cancer-But Only in Overweight or Obese Patients, reveals study Dr. Kamal Kant Kohli2 Dec 2024 9:15 AM ISTA widely accessible drug commonly used to control blood glucose levels in diabetic patients has the potential to strengthen the effects of...
Second-Hand Smoke Linked to 20 Percent Increased Lung Cancer Risk in Never-Smokers: Meta-Analysis Confirms Medha Baranwal28 Nov 2024 9:00 PM ISTItaly: A recent review, published in European Respiratory Review found that second-hand smoke (SHS) exposure increased the risk of lung cancer by 24%...
Robotics and Beyond: Advances in Lung Cancer Surgery Dr. Kamal Kant Kohli27 Nov 2024 6:00 AM ISTAs director of the Division of Thoracic Surgery in the Jim and Eleanor Randall Department of Surgery at Cedars-Sinai, Harmik J. Soukiasian, MD, and...
CT-Defined Coronary Artery Calcification may predict overall survival and major CV events in Lung Cancer patients: Study Dr.Niharika Harsha B22 Nov 2024 9:00 PM ISTA recent study published in the journal Academic Radiology found that coronary artery calcification can be used as a diagnostic tool for estimating...
